Gradient Investments LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$15,130
+101.5%
978
+104.6%
0.00%
Q2 2023$7,509
-4.7%
4780.0%0.00%
Q1 2023$7,877
+5.6%
4780.0%0.00%
Q4 2022$7,457
+24.3%
4780.0%0.00%
Q3 2022$6,000
-14.3%
4780.0%0.00%
Q2 2022$7,0000.0%4780.0%0.00%
Q1 2022$7,0000.0%4780.0%0.00%
Q4 2021$7,000
-12.5%
4780.0%0.00%
Q3 2021$8,0000.0%4780.0%0.00%
Q2 2021$8,000
-11.1%
4780.0%0.00%
Q1 2021$9,0000.0%4780.0%0.00%
Q4 2020$9,0000.0%4780.0%0.00%
Q3 2020$9,000
-30.8%
478
-32.3%
0.00%
-100.0%
Q2 2020$13,000
+85.7%
706
+47.7%
0.00%
Q1 2020$7,000
-22.2%
4780.0%0.00%
Q4 2019$9,000
+12.5%
4780.0%0.00%
Q3 2019$8,0000.0%4780.0%0.00%
Q2 2019$8,000
-20.0%
4780.0%0.00%
-100.0%
Q1 2019$10,000
+100.0%
478
+67.1%
0.00%
Q4 2018$5,0002860.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders